Widely known for his vast knowledge in this area, Dr. Rivkin recently authored a paper on permanent nonsurgical rhinoplasty with PMMA-collagen gel, the only permanent filler FDA-approved for cosmetic use.
LOS ANGELES, Sept. 7, 2022 /PRNewswire-PRWeb/ -- Permanent nonsurgical rhinoplasty is the future of nasal aesthetics, and Los Angeles's premier specialist Dr. Alexander Rivkin is blazing the path forward. Dr. Rivkin's latest study, "PMMA-collagen Gel in Nonsurgical Rhinoplasty Defects: A Methodological Overview and 15-year Experience" was published in August 2022 by Plastic and Reconstructive Surgery - Global Open, one of the world's most prestigious and widely read peer-reviewed medical journals that focus on all areas of plastic and reconstructive surgery. Dr. Rivkin's recent publication expands and refines upon his landmark first in the literature paper on this topic published in 2014, adding much-needed guidance on the safety and optimization of aesthetic results. Nonsurgical rhinoplasty (NSR) is an alternative to surgical rhinoplasty for patients who desire correction of mild-to-moderate aesthetic nasal defects but do not wish to undergo surgery due to concerns about risks, recovery time or cost.
The article seeks to fill a gap in medical literature by providing needed information on methods for safe injection of PMMA-collagen gel for nonsurgical rhinoplasty (NSR) from a leading physician. In his study, Dr. Rivkin draws on many years of experience treating more than 1000 NSR patients with PMMA-collagen gel to provide a discussion of relevant anatomy; a methodological overview, including patient selection and a video describing injection techniques, along with a discussion of follow-up and safety as well as nontechnical key considerations. This is the first methodological report of nonsurgical correction of aesthetic nasal defects with PMMA-collagen gel and provides important information gleaned from 15 years of experience‚ which can support physicians considering PMMA-collagen gel for NSR.
"My research details how to assess candidates, create an effective treatment plan for the best aesthetic results, optimize safety, as well as prevent, recognize and manage complications with this procedure," says Dr. Alexander Rivkin.
Link to article: https://journals.lww.com/prsgo/Fulltext/2022/08000/PMMA_collagen_Gel_in_Nonsurgical_Rhinoplasty.21.aspx
More about Dr. Alexander Rivkin:
Dr. Rivkin is a facial aesthetic specialist and Assistant Clinical Professor at the David Geffen / UCLA School of Medicine. He received his undergraduate degree from Columbia University and his medical degree from the Yale University School of Medicine. His residency in Otolaryngology/ Head and Neck Surgery was at the University of California San Diego School of Medicine. His practice, RIVKIN Aesthetics, is focused on developing and perfecting non-invasive, non-ablative cosmetic treatments. He is best known nationally for pioneering and popularizing the Non-Surgical Rhinoplasty procedure. In 2020 he published the largest statistically comprehensive study on Non-Surgical Rhinoplasty in the medical literature.
Dr. Rivkin has authored numerous peer-reviewed publications and chapters on non-surgical cosmetic treatments and serves as a lead investigator on FDA and NIH clinical trials on a regular basis. He frequently trains physicians from all over the world on optimizing advanced injection techniques and serves as an expert for national media, including the TODAY show, The Doctors, Good Morning America, Entertainment Tonight and EXTRA.
Dr. Rivkin divides his time between patient care, clinical research, physician education, media appearances, and lecturing at scientific conferences throughout the world.
RIVKIN Aesthetics is located at 435 N Roxbury Dr #100 in Beverly Hills, CA 90210 and 11645 Wilshire Blvd., Suite 800 in Los Angeles. For more information, please visit http://www.westsideaesthetics.com or call 310-443-5273.
Media Contact
Nico Stahl, RIVKIN Aesthetics, 310-443-5273, [email protected]
SOURCE RIVKIN Aesthetics
Share this article